Review paper
TPO versus TPO: the good, the bad, and the to be determined
Abstract
The first-generation thrombopoietic agents, recombinant human thrombopoietin (rhTPO) and pegylated human recombinant megakaryocyte growth and development factor (PEG-rHuMGDF), were developed following identification and cloning of human thrombopoietin (TPO) in 1994.1, 2 Unfortunately, formation of cross-reactive antibodies to PEG-rHuMGDF capable of neutralising endogenous TPO in a minority of patients halted clinical development of these agents...
Paper Details
Title
TPO versus TPO: the good, the bad, and the to be determined
Published Date
Oct 7, 2021
Volume
195
Issue
5
Pages
653 - 654
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History